Practice: Amino Acid Oxidation 2 centers on how amino acids are degraded and how their nitrogen is handled. A key idea is that amino acid breakdown commonly begins with a transaminase reaction that requires the cofactor PLP. In liver mitochondria, glutamate is converted to \(\alpha\)-ketoglutarate by oxidative deamination, linking amino acid catabolism to nitrogen disposal and the formation of urea.
The carbon skeletons of amino acids can enter central metabolism in different ways. Some amino acids are both glucogenic and ketogenic, while serine, cysteine, and alanine are catabolized to yield pyruvate, making them glucogenic. Amino acid degradation does not directly feed electrons into complex II of the electron transport chain; that role belongs to FAD-dependent processes rather than the amino acids themselves.
An important clinical connection is phenylketonuria, which results from failure of the first step converting phenylalanine to tyrosine. Detection of phenylacetate-related compounds supports diagnosis, and early restriction of phenylalanine helps protect brain development.
1
Concept
Practice
Video duration:
2m
Play a video:
Practice Video Summary
Amino acids play a crucial role in metabolism, being classified as both glucogenic and ketogenic. While all amino acids contribute to the generation of urea, none can directly interact with complex II of the electron transport chain; this function is specifically performed by FAD. In the liver mitochondria, the degradation of amino acids begins with transamination, where glutamate is converted to α-ketoglutarate through oxidative deamination.
Glucogenic amino acids, such as serine, cysteine, and alanine, are catabolized to produce pyruvate, which can then enter gluconeogenesis or the citric acid cycle. A notable genetic disorder related to amino acid metabolism is phenylketonuria (PKU), which arises from a defect in the enzyme responsible for converting phenylalanine to tyrosine. This metabolic block leads to the accumulation of phenylalanine and its byproducts, such as phenylacetate, which serve as markers for the condition. Newborns are routinely screened for these compounds to identify PKU early, allowing for dietary interventions that limit phenylalanine intake during critical periods of brain development.
Study Smarter with Worksheets.
Follow along with each video using our printable worksheets
Transamination is a crucial step in amino acid oxidation where the amino group from an amino acid is transferred to an alpha-keto acid, typically alpha-ketoglutarate. This process requires a cofactor called pyridoxal phosphate (PLP), derived from vitamin B6. The result is the formation of a new amino acid (usually glutamate) and a corresponding alpha-keto acid. This step is essential because it allows the removal of nitrogen from amino acids, facilitating their further catabolism. In the liver mitochondria, glutamate undergoes oxidative deamination to release free ammonia, which then enters the urea cycle for safe excretion. Thus, transamination links amino acid breakdown to nitrogen disposal and energy metabolism.
Glucogenic amino acids are those that can be converted into glucose precursors during catabolism. Examples include serine, cysteine, and alanine, which are catabolized to yield pyruvate, a key intermediate in gluconeogenesis. These amino acids contribute to maintaining blood glucose levels, especially during fasting or starvation. Their carbon skeletons enter metabolic pathways that generate glucose, providing energy to tissues that depend on glucose, such as the brain and red blood cells. Understanding which amino acids are glucogenic helps explain how protein breakdown supports energy homeostasis.
Phenylketonuria (PKU) is a genetic disorder caused by a defect in the enzyme phenylalanine hydroxylase, which converts phenylalanine to tyrosine. This defect leads to the accumulation of phenylalanine and its metabolites, such as phenylacetate, which can be toxic to the brain. Early diagnosis is critical because elevated phenylalanine levels during brain development can cause intellectual disability and neurological problems. Newborns are screened for phenylacetate as a marker of PKU. If detected early, a low-phenylalanine diet can be implemented to prevent these adverse effects, allowing normal cognitive development.
Urea formation is a consistent outcome of amino acid degradation because amino acids contain nitrogen in their amino groups, which must be safely removed from the body. During amino acid catabolism, the amino group is transferred to alpha-ketoglutarate via transamination, forming glutamate. Glutamate then undergoes oxidative deamination, releasing free ammonia (NH3). Ammonia is toxic, so it is converted into urea in the liver through the urea cycle. Urea is a non-toxic, water-soluble compound that is excreted in urine. This process prevents the accumulation of harmful nitrogenous waste and maintains nitrogen balance in the body.
No amino acid can directly interact with complex II of the electron transport chain. Instead, the cofactor flavin adenine dinucleotide (FAD) plays a key role in this process. During amino acid oxidation, certain reactions generate reduced FADH2, which donates electrons to complex II (succinate dehydrogenase) in the electron transport chain. This electron transfer contributes to ATP production. Amino acids themselves do not directly transfer electrons to the electron transport chain; rather, their catabolic intermediates and cofactors like FAD mediate this connection.
